Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 31,081 | 1,204 | 139 | 298 | 23,995 |
| Cost of Goods | 616 | 85 | N/A | N/A | 1,929 |
| Gross Profit | 30,465 | 1,119 | 139 | 298 | 22,066 |
| Operating Expenses | 228,198 | 172,954 | 100,899 | 87,388 | 70,795 |
| Operating Income | -197,117 | -171,750 | -100,760 | -87,090 | -47,800 |
| Interest Expense | 15,579 | 13,101 | 2,780 | 802 | 14,544 |
| Other Income | 12,293 | 7,732 | 1,596 | 134 | 3,770 |
| Pre-tax Income | -200,403 | -177,119 | -101,944 | -87,758 | -58,574 |
| Net Income Continuous | -200,403 | -177,119 | -101,944 | -87,758 | -58,574 |
| Net Income | $-200,403 | $-177,119 | $-101,944 | $-87,758 | $-58,574 |
| EPS Basic Total Ops | -0.63 | -0.80 | -0.62 | -0.60 | -0.53 |
| EPS Basic Continuous Ops | -0.63 | -0.80 | -0.62 | -0.60 | -0.53 |
| EPS Diluted Total Ops | -0.63 | -0.80 | -0.62 | -0.60 | -0.53 |
| EPS Diluted Continuous Ops | -0.63 | -0.80 | -0.62 | -0.60 | -0.53 |
| EPS Diluted Before Non-Recurring Items | -0.63 | -0.79 | -0.62 | -0.60 | -0.52 |
| EBITDA(a) | $-194,738 | $-169,422 | $-99,592 | $-86,744 | $-43,853 |